Patents by Inventor Gaetan Munier

Gaetan Munier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9687539
    Abstract: The present invention concerns CD4+ T survivin epitopes and their vaccines and diagnostic uses.
    Type: Grant
    Filed: October 9, 2014
    Date of Patent: June 27, 2017
    Assignee: Commissariat a l'Energie Atomique
    Inventors: XiaoFei Wang, Gaetan Munier, Sandra Moratille, Helene Nuyttens, Bernard Maillere
  • Publication number: 20150050304
    Abstract: The present invention concerns CD4+ T survivin epitopes and their vaccines and diagnostic uses.
    Type: Application
    Filed: October 9, 2014
    Publication date: February 19, 2015
    Inventors: XiaoFei Wang, Gaetan Munier, Sandra Moratille, Helene Nuyttens, Bernard Maillere
  • Publication number: 20090130134
    Abstract: The invention relates to immunogenic peptides from EBV type I and II latency antigens, comprising at least one T CD4+ epitope which can be recognized by the majority of individuals in the Caucasian population. The invention also relates to the diagnostic and therapeutic applications of same.
    Type: Application
    Filed: February 2, 2006
    Publication date: May 21, 2009
    Inventors: Veronique Pancre, Claude Auriault, Stephane Depil, Bernard Maillere, Olivier Morales, Gaetan Munier
  • Publication number: 20090004214
    Abstract: The invention concerns CD4+ T survivin epitopes and their vaccine and diagnostic uses.
    Type: Application
    Filed: September 28, 2006
    Publication date: January 1, 2009
    Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE
    Inventors: XiaoFei Wang, Gaetan Munier, Sandra Moratille, Helene Nuyttens, Bernard Maillere